Search JIM Advanced Search

Journal of Chinese Integrative Medicine ›› 2012, Vol. 10 ›› Issue (4): 357-361.doi: 10.3736/jcim20120401

    Next Articles

The European directive on traditional herbal medicinal products: friend or foe for plant-based therapies?

Thomas Efferth1(), Henry Johannes Greten2,3   

  1. 1. Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Staudinger Weg 5, 55128 Mainz, Germany
    2. Heidelberg School of Chinese Medicine, Karlsruher Straβe 12, 69126 Heidelberg, Germany
    3. Biomedical Sciences Institute Abel Salazar, University of Porto, Porto, Portugal
  • Received:2012-02-23 Accepted:2012-02-25 Online:2012-04-20 Published:2018-04-15

Key words: plants, medicinal, complementary medicine, drug interactions, drugs, non-prescription, quality control, European Union

[1] The European Parliament and the Council of the European Union. Directive 2004/24/EC of the European Parliament and of the Council of 31 March 2004 amending, as regards traditional herbal medicinal products, Directive 2001/83/EC on the Community code relating to medicinal products for human use. ( 2004-04-30) [2012-02-17].
[2] The European Parliament and the Council of the European Union. Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use. (2001- 11-28)[ 2012-02-17]. .
[3] Medicines and Healthcare products Regulatory Agency UK. Guidance forRetailers, Wholesalers, Importers and Manufacturers on the Requirements of the THMRS. ( 2007 -03) [2012-02-17].
[4] Medicines and Healthcare products Regulatory Agency, UK. Guidance on Use of HMPC Monographs to Demonstrate Safety and Traditional Use. ( 2007 -12) [2012-02-17].
[5] Medicines and Healthcare products Regulatory Agency, UK. Organic Herbal Ingredients and Labelling under the Traditional Herbal Medicines Registration (THR) Scheme : Guidance for Applicants/ Registration Holders.[2012-02-17] .
[6] Medicines and Healthcare products Regulatory Agency, UK. Guidance on Transitional Arrangements for the Directive on Traditional Herbal Medicinal Products (Directive 2004/24/EC, amending Directive 2001/83/ EC). (2010-08)[ 2012-02-17]. .
[7] Medicines and Healthcare products Regulatory Agency, UK. Registered Traditional Herbal Medicines: Guidance on Consumer Advertising. (2009-10)[ 2012-02-17] . .
[8] Medicines and Healthcare products Regulatory Agency, UK. Guidance on Arrangements for the Transfer of Certain Herbal Products with a Marketing Authorisation to Traditional Herbal Registration Status. ( 2009 -01) [2012-02-17].
[9] Medicines and Healthcare products Regulatory Agency, UK. Public Perceptions of Herbal Medicines: General Public Qualitative and Quantitative Research. ( 2008 - 11) [2012-02-17].
[10] Encyclopedia Britannica. Food.[ 2012-02-17] . .
[11] Wikipedia. Dietary supplements.[2012-02-17]. .
[12] European Commission. Health and Nutritional Claims. ( 2009 -11-20 ) [2012-02-17]. .
[13] Encyclopedia Britannica. Medicine. [2012-02-17]..
[14] The European Parliament and the Council of the European Union. Regulation (EC) No. 178/2002 of the European Parliament and of the Council of 28 January 2002 laying down the general principles and requirements of food law, establishing the European Food Safety Authority laying down procedures in matters of food safety. (2002-02-01)[ 2012-02-17]. .
[15] The European Parliament and the Council of the European Union. Regulation (EC) No 258/97 of the European Parliament and of the Council of 27 January 1997 concerning novel foods and novel food ingredients. (1997-02-14)[ 2012-02-17]. .
[16] The European Parliament and the Council of the European Union. Directive 2002/46/EC of the European Parliament and of the Council of 10 June 2002 on the approximation of the laws of the Member States relating to food supplements. ( 2002-07-12) [2012-02-17]. .
[17] EFSA Scientific Committee. Guidance on Safety assessment of botanicals and botanical preparations intended for use as ingredients in food supplements. EFSA J. 2009; 7(9) : 1249-1273.
[18] Efferth T, Kaina B . Toxicities by herbal medicines with emphasis to traditional Chinese medicine. Curr Drug Metab. 2011; 12(10):989-996.
doi: 10.2174/138920011798062328
[19] Youns M, Hoheisel JD, Efferth T . Toxicogenomics for the prediction of toxicity related to herbs from traditional Chinese medicine. Planta Med. 2010; 76(17):2019-2025.
doi: 10.1055/s-0030-1250432
[20] Eichhorn T, Greten HJ, Efferth T . Self-medication with nutritional supplements and herbal over-the-counter products. Nat Products Bioprospect. 2011 ; 1(2) : 62-70.
doi: 10.1007/s13659-011-0029-1
[21] Kober M, Pohl K, Efferth T . Molecular mechanisms underlying St. John’s wort drug interactions. Curr Drug Metab. 2008; 9(10):1027-1037.
doi: 10.2174/138920008786927767
[22] Efferth T, Koch E . Complex interactions between phytochemicals. The multi-target therapeutic concept of phytotherapy. Curr Drug Targets . 2011 ; 12(1) : 122-132.
doi: 10.2174/138945011793591626
[23] Jia H . Traditional Chinese medicines hampered by EU regulations. ( 2011 -06-10) [2012-02-17]. .
[24] Lewith G, Barlow F, Eyles C, Flower A, Hall S, Hopwood V, Walker J . The context and meaning of placebos for complementary medicine. Forsch Komple- mentmed. 2009; 16(6):404-412.
[25] Staud R . Effectiveness of CAM therapy: understanding the evidence. Rheum Dis Clin North Am. 2011 ; 37(1):9-17.
doi: 10.1016/j.rdc.2010.11.009
[26] Lincoln T . Toxicology: danger in the diet. Nature. 2007; 448(7150) : 148.
doi: 10.1038/448148a
[27] Konkimalla VB, Efferth T . Evidence-based Chinese medicine for cancer therapy.J Ethnopharmacol. 2008; 116(2):207-210.
doi: 10.1016/j.jep.2007.12.009
[28] Efferth T, Li PC, Konkimalla VS, Kaina B . From traditional Chinese medicine to rational cancer therapy. Trends Mol Med. 2007; 13(8):353-361.
doi: 10.1016/j.molmed.2007.07.001
[29] Efferth T, Fu YJ, Zu YG, Schwarz G, Konkimalla VS, Wink M . Molecular target-guided tumor therapy with natural products derived from traditional Chinese medicine. Curr Med Chem. 2007; 14(19):2024-2032.
doi: 10.2174/092986707781368441
[30] Abdel-Rahman A, Anyangwe N, Carlacci L, Casper S, Danam RP, Enongene E, Erives G, Fabricant D, Gudi R, Hilmas CJ, Hines F, Howard P, Levy D, Lin Y, Moore RJ, Pfeiler E, Thurmond TS, Turujman S, Walker NJ . The safety and regulation of natural products used as foods and food ingredients. Toxicol Sci. 2011 ; 123(2):333-348.
doi: 10.1093/toxsci/kfr198
[31] Gao H, Wang Z, Li Y, Qian Z . Overview of the quality standard research of traditional Chinese medicine. Front Med. 2011; 5(2) : 195-202.
doi: 10.1007/s11684-011-0134-x
[32] Ruparel P, Lockwood B . The quality of commercially available herbal products. Nat Prod Commun. 2011; 6(5):733-744.
[33] Li SP, Zhao J, Yang B . Strategies for quality control of Chinese medicines.J Pharm Biomed Anal. 2011 ; 55(4):802-809.
doi: 10.1016/j.jpba.2010.12.011
[34] Cosyns JP . Aristolochic acid and “Chinese herbs nephropathy” : a review of the evidence to date. Drug Saf. 2003; 26(1):33-48.
doi: 10.2165/00002018-200326010-00004
[35] Nortier JL, Vanherweghem JL . Renal interstitial fibrosis and urothelial carcinoma associated with the use of a Chinese herb ( Aristolochia fang chi ). Toxicology. 2002; 181-182:577-580.
doi: 10.1016/S0300-483X(02)00486-9
[36] Debelle FD, Vanherweghem JL, Nortier JL . Aristolochic acid nephropathy: a worldwide problem. Kidney Int. 2008; 74(2) : 158-169.
doi: 10.1038/ki.2008.129
[1] Kayode Ezekiel Adewole. Nigerian antimalarial plants and their anticancer potential: A review. Journal of Integrative Medicine, 2020, 18(2): 92-113.
[2] Deng-hai Zhang, Kun-lun Wu, Xue Zhang, Sheng-qiong Deng, Bin Peng. In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus. Journal of Integrative Medicine, 2020, 18(2): 152-158.
[3] Yogesh Subhash Biradar, Swathi Bodupally, Harish Padh. Evaluation of antiplasmodial properties in 15 selected traditional medicinal plants from India. Journal of Integrative Medicine, 2020, 18(1): 80-85.
[4] Dona Nirmani Ann Wijewickrama Samarakoon, Deepthi Inoka Uluwaduge, Malith Aravinda Siriwardhene. Mechanisms of action of Sri Lankan herbal medicines used in the treatment of diabetes: A review. Journal of Integrative Medicine, 2020, 18(1): 13-20.
[5] Md. Anzar Alam, Mohd Aleemuddin Quamri, Ghulamuddin Sofi, Barkati Md.Tarique. Understanding hypothyroidism in Unani medicine. Journal of Integrative Medicine, 2019, 17(6): 387-391.
[6] Naghmeh Yazdi, Alireza Salehi, Mina Vojoud, Mohammad Hossein Sharifi, Ayda Hoseinkhani. Use of complementary and alternative medicine in pregnant women: a cross-sectional survey in the south of Iran. Journal of Integrative Medicine, 2019, 17(6): 392-395.
[7] Zienab Mahmoudpour, Javad Shokri, Mohammad Kamalinejad, Neda Meftah, Soraya Khafri, Seyyed Ali Mozaffarpur, Hoda Shirafkan. The efficacy of a Persian herbal formulation on functional bloating: A double-blind randomized controlled trial. Journal of Integrative Medicine, 2019, 17(5): 344-350.
[8] Rebecca Kulbida, Alexander Mathes, Johannes Loeser. Beneficial effects of hirudotherapy in a chronic case of complex regional pain syndrome. Journal of Integrative Medicine, 2019, 17(5): 383-386.
[9] Deepak Kumar Semwal, Ashutosh Chauhan, Ankit Kumar, Sonali Aswal, Ruchi Badoni Semwal, Abhimanyu Kumar. Status of Indian medicinal plants in the International Union for Conservation of Nature and the future of Ayurvedic drugs: Shouldn’t think about Ayurvedic fundamentals?. Journal of Integrative Medicine, 2019, 17(4): 238-243.
[10] Shipra Shah, Jahangeer A. Bhat. Ethnomedicinal knowledge of indigenous communities and pharmaceutical potential of rainforest ecosystems in Fiji Islands. Journal of Integrative Medicine, 2019, 17(4): 244-249.
[11] Mohammad Hossein Ayati, Ata Pourabbasi, Nazli Namazi, Arman Zargaran, Zahra Kheiry, Amir Hooman Kazemi, Bagher Larijani. The necessity for integrating traditional, complementary, and alternative medicine into medical education curricula in Iran. Journal of Integrative Medicine, 2019, 17(4): 296-301.
[12] Baxter Blonk, Ian E. Cock. Interactive antimicrobial and toxicity profiles of Pittosporum angustifolium Lodd. extracts with conventional antimicrobials. Journal of Integrative Medicine, 2019, 17(4): 261-272.
[13] Tamer Aboushanab, Mohamed Khalil, YaserAl Ahmari. The present state of complementary medicine regulation in Saudi Arabia. Journal of Integrative Medicine, 2019, 17(3): 147-149.
[14] Rachael Farrington, Ian F.Musgrave, Roger W.Byard. Evidence for the efficacy and safety of herbal weight loss preparations. Journal of Integrative Medicine, 2019, 17(2): 87-92.
[15] Hanae Naceiri Mrabti, Nidal Jaradat, Mohamed Reda Kachmar, Abdelaziz Ed-Dra, Abdelilah Ouahbi, Yahia Cherrah, Moulay El Abbes Faouzi. Integrative herbal treatments of diabetes in Beni Mellal region of Morocco. Journal of Integrative Medicine, 2019, 17(2): 93-99.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Zhi-chun Jin. Problems in establishing clinical guideline for integrated traditional Chinese and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 5-8
[2] SUN Ming-yu, ZUO Jian, DUAN Ji-feng, HAN Jun, FAN Shi-ming, ZHANG Wei, ZHU Li-fang, YAO Ming-hui. Antitumor activities of kushen flavonoids in vivo and in vitro. Journal of Chinese Integrative Medicine, 2008, 6(1): 51-59
[3] Wei Zhang, Xiang-feng Lu, Xiao-mei Zhang, Jian-jun Wu, Liang-duo Jiang. A rat model of pulmonary fibrosis induced by infusing bleomycin quickly through tracheal intubation. Journal of Chinese Integrative Medicine, 2008, 6(1): 60-67
[4] Min Cheng, Qiong Feng, Shu-wen Qian, Hui Gao, Cui-qing Zhu. Preliminary assay of p-amyloid binding elements in heart-beneficial recipe. Journal of Chinese Integrative Medicine, 2008, 6(1): 68-72
[5] Jin-zhou Tian, Jing Shi, Xin-qing Zhang, Qi Bi, Xin Ma, Zhi-liang Wang, Xiao-bin Li, Shu-li Shen, Lin Li, Zhen-yun Wu, Li-yan Fang, Xiao-dong Zhao, Ying-chun Miao, Peng-wen Wang, Ying Ren, Jun-xiang Yin, Yong-yan Wang, Beijing United Study Group on MCI of the Capital Foundation of Medical Developments. Guiding principles of clinical research on mild cognitive impairment (protocol). Journal of Chinese Integrative Medicine, 2008, 6(1): 9-14
[6] Ya-bing Zhou, Jian-er Yu, Jie Wu, Li Bai, Li-li Huo, Xin-guang Zhang, Li-qing Li . Effects of Chinese herbal medicine Bushen Gubiao Recipe on toll-like receptor 4 and CD4 +CD25 +foxp3 +regulatory T cells in mice with recurrent respiratory tract infections. Journal of Chinese Integrative Medicine, 2010, 8(11): 1053-1059
[7] Jing-yuan Mao, Chang-xiao Liu, Heng-he Wang, Guang-li Wei , Zhen-peng Zhang, Jie Xing, Wang Xian liang , Ying-fei Bi . Effects of Shenmai Injection on serum concentration and pharmacokinetics of digoxin in dogs with heart failure. Journal of Chinese Integrative Medicine, 2010, 8(11): 1070-1074
[8] Chan Chen, Yong-mei Meng , Peng Zhang, Juan Wang, Hui-hui Zhao, Shu-zhen Guo , Wei Wang. Diagnosis and treatment rule of traditional Chinese medicine for syndrome factors of chronic congestive heart failure: a study based on Shannon entropy method. Journal of Chinese Integrative Medicine, 2010, 8(11): 1080-1084
[9] Zhao-guo Li . A discussion of English translation of 1995 and 1997 Chinese National Standards of Traditional Chinese Medical Terminologies for Clinical Diagnosis and Treatment. Journal of Chinese Integrative Medicine, 2010, 8(11): 1090-1096
[10] Zhi-mei Wang, Bin Zhang. A study on translation of ellipses in Huangdi Neijing from perspective of hermeneutic theory. Journal of Chinese Integrative Medicine, 2010, 8(11): 1097-1100